Effects of anti-CD20 treatment beyond B cell depletion: Reduction of endogenous sTACI

被引：0

作者：

Mader, Simone ^{[1
]}

Thaler, Franziska ^{[1
,2
]}

Fichtner, Miriam ^{[1
]}

Ho, Samantha ^{[1
]}

Oswald, Eva ^{[1
]}

Wong, Hoi Kiu ^{[1
]}

Vural, Atay ^{[3
]}

Yilmaz, Vuslat ^{[4
]}

Tuezuen, Erdem ^{[4
]}

Turkoglu, Recai ^{[5
]}

Straub, Tobias ^{[6
]}

Smolle, Michalea ^{[7
]}

Schaller, Jonas ^{[1
]}

Feederle, Regina ^{[8
]}

Bultmann, Andreas ^{[9
]}

Schneider, Pascal ^{[10
]}

Meinl, Ingrid

Kuempfel, Tania

Meinl, Edgar ^{[1
]}

机构：

[1] Ludwig Maximilians Univ Munchen, Inst Clin Neuroimmunol, Biomed Ctr & Univ Hosp, Munich, Germany

[2] Munich Cluster Syst Neurol SyNergy, Munich, Germany

[3] Koc Univ, Dept Neurol, Sch Med, Istanbul, Turkiye

[4] Aziz Sancar Inst Expt Med, Dept Neurosci, Istanbul, Turkiye

[5] Haydarpasa Numune Educ & Res Hosp, Dept Neurol, Istanbul, Turkiye

[6] Ludwig Maximilians Univ Munchen, Biomed Ctr, Core Facil Bioinformat, Martinsried, Germany

[7] Ludwig Maximilians Univ Munchen, Physiol Chem, BMC, Martinsried, Germany

[8] German Res Ctr Environm Hlth, Monoclonal Antibody Core Facil, Helmholtz Zentrum Munchen, Neuherberg, Germany

[9] MorphoSys AG, Planegg, Germany

[10] Univ Lausanne, Dept Immunobiol, Lausanne, Switzerland

来源：

MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P685/217

引用

页码：592 / 593

页数：2

共 50 条

[41] Anti-CD20 treatment for B-cell malignancies: current status and future directions
Klein, Christian
Jamois, Candice
Nielsen, Tina
EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (02) : 161 - 181
[42] Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody
Yasser Abou Mourad
Ali Taher
Aref Chehal
Ali Shamseddine
Annals of Hematology, 2004, 83 : 319 - 321
[43] Anti-CD20 Antibody Therapy for B-Cell Lymphomas
Taylor, Ronald P.
Lindorfer, Margaret A.
Zent, Clive S.
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09) : 876 - 877
[44] ANTI-CD3 THERAPY INDUCES RAPID RENAISSANCE OF B220low B LYMPHOCYTES FOLLOWING B-CELL DEPLETION BY ANTI-CD20
Wu, Gordon D.
Klein, Andrew S.
TRANSPLANT INTERNATIONAL, 2009, 22 : 15 - 15
[45] Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice
Dai, Guixiang
Noell, Kristin
Weckbecker, Gisbert
Kolls, Jay K.
MSPHERE, 2021, 6 (03): : 1 - 9
[46] Effect of anti-cd20 antibody-induced b-cell depletion on the susceptibility to streptococcus pneumoniae infections
Ercoli, G.
Ramos-Sevillano, E.
Folkmanaite, M.
Leandro, M.
Cambridge, G.
Weckbecker, G.
Brown, J.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 275 - 275
[47] Depletion of B cells by anti-CD20 inhibits development of spontaneous autoimmune thyroiditis (SAT)
Yu, Shiguang
Braley-Mullen, Helen
FASEB JOURNAL, 2008, 22
[48] B cell activation influences antigen presentation, proinflammatory T cell polarization and response to anti-CD20 B cell depletion in CNS autoimmunity
Martin, Weber
Thomas, Prod'homme
Carlos, Patarroyo Juan
Nicolas, Molnarfi
Tara, Karnezis
Klaus, Lehmann-Horn
Dimitry, Danilenko
Jeffrey, Eastham-Anderson
Anthony, Slavin
Christopher, Linington
Claude, Bernard
Flavius, Martin
Scott, Zamvil
JOURNAL OF NEUROIMMUNOLOGY, 2010, 228 (1-2) : 136 - 136
[49] Effect of anti-cd20 antibody-mediated b-cell depletion on susceptibility to a pneumocystis infection in mice
Dai, G.
Weckbecker, G.
Kolls, J. K.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 275 - 275
[50] Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab)
Bruzzese, V.
Pepe, J.
REUMATISMO, 2009, 61 (04) : 306 - 308

← 1 2 3 4 5 →